Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age
Clinical trial NCT05727215 · COMPLETED
Trial details
- NCT number
- NCT05727215
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-02-22
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.